10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever WuXi Biologics (Cayman) Inc, an investment holding company, provides end-to ...

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) was the target of a significant decline in short interest in the month of December.As of December 31st, there was short interest totalling ...

WuXi Biologics differentiates itself from other ... we consider small biotech customers less favorable due to their high sensitivity to interest rates or to sentiment swings in the biofunding ...

WuXi AppTec, a prominent Chinese company listed on the Shanghai Stock Exchange, has announced the sale of its cell and gene therapy manufacturing unit, WuXi Advanced Therapies, to U.S.-based ...

SHANGHAI, Jan. 12, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences ...

According to the report, WuXi Biologics is working with advisers to gauge interest from potential bidders for its European production facilities, including two in Germany and one in Ireland.

WuXi Biologics' CEO Chris Chen has denied that ... our overall margin profile [after the sale will have] improved by 100 bps [basis points, equivalent to 1%]. Why wouldn’t we do it?